Esperion Therapeutics
ESPR
ESPR
131 hedge funds and large institutions have $987M invested in Esperion Therapeutics in 2017 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 39 increasing their positions, 51 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
10% more funds holding
Funds holding: 119 → 131 (+12)
24% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 51
71% less call options, than puts
Call options by funds: $29.9M | Put options by funds: $103M
Holders
131
Holding in Top 10
7
Calls
$29.9M
Puts
$103M
Top Buyers
| 1 | +$50.6M | |
| 2 | +$27M | |
| 3 | +$26.2M | |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$14.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$13.2M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$11.1M | |
| 3 | -$8.33M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$6.85M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.4M |